I was just looking at the YMB on the stock page for CXM and saw the latest news article posted there dated Mon. Oct. 29th : " FDA Considering Faster Approval Process for Developers of Drugs for Deadly or Debilitating Diseases" . This sounded very familiar, like it was an older article we had already discussed, but thought I would mention it for comments/feedback from you guys.

In this article, there is a company called Orexigen trying to get approval for it's drug called Contrave that apparently was either rejected or got a CRL in 2011. The company is quoted as saying that they are "In discussions with the FDA about speeding up regulatory review and that the FDA is open to discussing options ".

I know that the topic of trying to get "faster approval" for MNKD has been discussed before, but wondered if anything has changed on that horizon recently with the approval of some obesity drugs lately ? Appreciate anyones comments/input - anxious as always !

GO MNKD ! GO DR. MANN !